FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2130711231> ?p ?o ?g. }

• W2130711231 abstract "“Sequential” or “concomitant” non-bismuth quadruple regimens are currently recommended by the recent updated (Maastricht IV) European guidelines as alternative to bismuth based quadruple regimen first line therapies, in areas with a high rate (over 20%) of clarithromycin resistance [1]. Besides this, there is no trial comparing both regimens in settings with increasing rates of clarithromycin resistance [2]. In a recent prospective, randomized, multicenter, clinical trial, conducted in Spain, McNicholl et al aimed to compare the effectiveness and safety of these therapies for Helicobacter pylori (H. pylori) eradication [3].They included a large number of patients (n=338) with non-investigated/functional dyspepsia (80%) or peptic ulcer disease (20%), naive to eradication therapy. Mean age was 47 years, 60% were women and 20% smokers. They were randomly assigned to sequential treatment; omeprazole (20 mg/12 h) and amoxycilline (1 g/12 h) for 5 days, followed by 5 days of omeprazole (20 mg/12 h), clarithromycin (500 mg/12 h) and metronidazole (500 mg/12 h)[170 patients (50.3%)] or concomitant treatment; same drugs at the same doses taken concomitantly for 10 days [168 patients (49.7%)]. Eradication was confirmed with 13C-urea breath test or histology (depending on the indication), at least 4 weeks after treatment. Treatment related adverse events and adherence to treatment were also carefully evaluated.A total of 302 patients completed the follow up and were tested for H. pylori eradication. The success rate of either regimen was defined as the primary outcome measure and was expressed both by intention-to-treat and per protocol. Secondary outcomes included the rate of treatment-emergent adverse events (AE’s) and patients’ adherence to treatment. Concomitant and sequential eradication rates were respectively, 87% versus 81% by intention-to-treat (P=0.15) and 91% versus 86% (P=0.13%) per protocol. Multivariate analysis showed an odds ratio of 1.5 towards better eradication rate with concomitant regimen of borderline significance (OR 1.5, 95% CI 0.9-2.8). Respective adherences to treatment were satisfactory and comparable between treatments (83% versus 82%). AE’s were reported by as many as 59% of their patients but were mostly mild (60%), leading to treatment discontinuation in only 12 patients. In conclusion, the concomitant regimen had a non-significant advantage over sequential therapy and was the only one overcoming the 90% cure rate, per protocol. Both therapies were well tolerated and safe." @default.
• W2130711231 created "2016-06-24" @default.
• W2130711231 creator A5069298781 @default.
• W2130711231 date "2014-01-01" @default.
• W2130711231 modified "2023-09-23" @default.
• W2130711231 title "Concomitant or sequential eradication of Helicobacter pylori: which regimen comes first?" @default.
• W2130711231 cites W1509958316 @default.
• W2130711231 cites W1608319452 @default.
• W2130711231 cites W1982900653 @default.
• W2130711231 cites W1997115882 @default.
• W2130711231 cites W2017178544 @default.
• W2130711231 cites W2022948175 @default.
• W2130711231 cites W2023331043 @default.
• W2130711231 cites W2042102752 @default.
• W2130711231 cites W2059710519 @default.
• W2130711231 cites W2064401560 @default.
• W2130711231 cites W2066955421 @default.
• W2130711231 cites W2079086304 @default.
• W2130711231 cites W2093958797 @default.
• W2130711231 cites W2109456597 @default.
• W2130711231 cites W2111942462 @default.
• W2130711231 cites W2124176837 @default.
• W2130711231 cites W2127635131 @default.
• W2130711231 cites W2153165213 @default.
• W2130711231 cites W2158819521 @default.
• W2130711231 cites W2163544908 @default.
• W2130711231 cites W2165481475 @default.
• W2130711231 cites W2167283196 @default.
• W2130711231 cites W2170167645 @default.
• W2130711231 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4073033" @default.
• W2130711231 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24976082" @default.
• W2130711231 hasPublicationYear "2014" @default.
• W2130711231 type Work @default.
• W2130711231 sameAs 2130711231 @default.
• W2130711231 citedByCount "1" @default.
• W2130711231 countsByYear W21307112312021 @default.
• W2130711231 crossrefType "journal-article" @default.
• W2130711231 hasAuthorship W2130711231A5069298781 @default.
• W2130711231 hasConcept C126322002 @default.
• W2130711231 hasConcept C141071460 @default.
• W2130711231 hasConcept C168563851 @default.
• W2130711231 hasConcept C197934379 @default.
• W2130711231 hasConcept C202953159 @default.
• W2130711231 hasConcept C2776409635 @default.
• W2130711231 hasConcept C2776962512 @default.
• W2130711231 hasConcept C2777172195 @default.
• W2130711231 hasConcept C2777396551 @default.
• W2130711231 hasConcept C2777498785 @default.
• W2130711231 hasConcept C2779384505 @default.
• W2130711231 hasConcept C2781413609 @default.
• W2130711231 hasConcept C2908868296 @default.
• W2130711231 hasConcept C501593827 @default.
• W2130711231 hasConcept C71924100 @default.
• W2130711231 hasConcept C86803240 @default.
• W2130711231 hasConcept C89423630 @default.
• W2130711231 hasConcept C90924648 @default.
• W2130711231 hasConceptScore W2130711231C126322002 @default.
• W2130711231 hasConceptScore W2130711231C141071460 @default.
• W2130711231 hasConceptScore W2130711231C168563851 @default.
• W2130711231 hasConceptScore W2130711231C197934379 @default.
• W2130711231 hasConceptScore W2130711231C202953159 @default.
• W2130711231 hasConceptScore W2130711231C2776409635 @default.
• W2130711231 hasConceptScore W2130711231C2776962512 @default.
• W2130711231 hasConceptScore W2130711231C2777172195 @default.
• W2130711231 hasConceptScore W2130711231C2777396551 @default.
• W2130711231 hasConceptScore W2130711231C2777498785 @default.
• W2130711231 hasConceptScore W2130711231C2779384505 @default.
• W2130711231 hasConceptScore W2130711231C2781413609 @default.
• W2130711231 hasConceptScore W2130711231C2908868296 @default.
• W2130711231 hasConceptScore W2130711231C501593827 @default.
• W2130711231 hasConceptScore W2130711231C71924100 @default.
• W2130711231 hasConceptScore W2130711231C86803240 @default.
• W2130711231 hasConceptScore W2130711231C89423630 @default.
• W2130711231 hasConceptScore W2130711231C90924648 @default.
• W2130711231 hasLocation W21307112311 @default.
• W2130711231 hasOpenAccess W2130711231 @default.
• W2130711231 hasPrimaryLocation W21307112311 @default.
• W2130711231 hasRelatedWork W1509958316 @default.
• W2130711231 hasRelatedWork W1829107152 @default.
• W2130711231 hasRelatedWork W1969010805 @default.
• W2130711231 hasRelatedWork W1971782748 @default.
• W2130711231 hasRelatedWork W1973678913 @default.
• W2130711231 hasRelatedWork W1982900653 @default.
• W2130711231 hasRelatedWork W1997115882 @default.
• W2130711231 hasRelatedWork W2059710519 @default.
• W2130711231 hasRelatedWork W2063563581 @default.
• W2130711231 hasRelatedWork W2066955421 @default.
• W2130711231 hasRelatedWork W2076102225 @default.
• W2130711231 hasRelatedWork W2128527034 @default.
• W2130711231 hasRelatedWork W2138283672 @default.
• W2130711231 hasRelatedWork W2159142230 @default.
• W2130711231 hasRelatedWork W2165481475 @default.
• W2130711231 isParatext "false" @default.
• W2130711231 isRetracted "false" @default.
• W2130711231 magId "2130711231" @default.
• W2130711231 workType "article" @default.